CA
NZ
UK
AU
IND
US
Conexeu Sciences Inc. (NASDAQ:CNXU) shares fell 12.15% to $7.81 in the latest closing session, placing the stock among the day's most notable decliners.
Azenta, Inc. (NASDAQ:AZTA) shares fell 12.09% to $32.88 in the latest closing session, placing the stock among the day's most notable decliners.
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) shares fell 13.11% to $5.40 in the latest closing session, placing the stock among the day's most notable decliners.
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares fell 10.07% to $2.41 in the latest closing session, placing the stock among the day's most notable decliners.
Alvotech (NASDAQ: ALVO) shares closed up 19% at $5.27 as BofA Securities initiated coverage on the biosimilar specialist with a Buy rating and a $7 price target.
Alvotech (NASDAQ: ALVO) shares closed up 19% at $5.27 as BofA Securities initiated coverage on the biosimilar specialist with a Buy rating and a $7 price target.
Jupiter Neurosciences, Inc. (NASDAQ: JUNS) shares fell 9% to $5.66 after the company reported a Q2 net loss of $2.27 million on $0.02 million in revenue.
NewcelX filed a resale prospectus covering up to 694,000 shares held by selling stockholders following its July private placement.
REGENXBIO Inc. (NASDAQ: RGNX) shares fell 25% to $8.06 after an FDA clinical hold on RGX-121 for MPS II, caused by asymptomatic spinal MRI findings in five CAMPSIITE participants, delayed its BLA resubmission.
Autonomix Medical, Inc. (NASDAQ: AMIX) is set to receive U.S. Patent No. 12,714,780, encompassing specialized systems and methods designed to regulate the growth, function, and development of organs and tumors.
Please wait processing your request...